The synthesis and full characterization of the new aqua-complex [(η6-p-cymene)Ru(OH2)(κ2-N,N-2-pydaT)](BF4)2, [2](BF4)2, and the nucleobase derivative [(η6-p-cymene)Ru(9-MeG)(κ2-N,N-2-pydaT)](BF4)2, [4](PF6)2, where 2-pydaT = 2,4-diamino-6-(2-pyridyl)-1,3,5-triazine and 9-MeG = 9-methylguanine, are reported here. The crystal structures of both [4](PF6)2 and the chloro complex [(η6-p-cymene)RuCl(κ2-N,N-2-pydaT)](PF6), [1](PF6), have been elucidated by X-ray diffraction. The former provided relevant information regarding the interaction of the metallic fragment [(η6-p-cymene)Ru(κ2-N,N-2-pydaT)]2+ and a simple model of DNA. NMR and kinetic absorbance studies have proven that the aqua-complex [2](BF4)2 binds to the N7 site of guanine in nucleobases, nucleotides, or DNA. A stable bifunctional interaction (covalent and partially intercalated) between the [(η6-p-cymene)Ru(κ2-N,N-2-pydaT)]2+ fragment and CT-DNA has been corroborated by kinetic, circular dichroism, viscometry, and thermal denaturation experiments. The reaction mechanism entails the very fast formation of the Ru–O-(PO3) linkage prior to the fast intercalation of the 2-pydaT fragment. Then, a Ru–N7-(G) covalent bond is formed at the expense of the Ru–O-(PO3) bond, yielding a bifunctional complex. The dissociation rate of the intercalated fragment is slow, and this confers additional interest to [2](BF4)2 in view of the likely correlation between slow dissociation and biological activity, on the assumption that DNA is the only biotarget. Furthermore, [2](BF4)2 displays notable pH-dependent cytotoxic activity in human ovarian carcinoma cells (A2780, IC50 = 11.0 μM at pH = 7.4; IC50 = 6.58 μM at pH = 6.5). What is more, complex [2](BF4)2 is not cross-resistant with cisplatin, exhibiting a resistance factor, RF(A2780cis), of 0.28, and it shows moderate selectivity toward the cancer cell lines, in particular, A2780cis (IC50 = 3.0 5 ± 0.08 μM), relative to human lung fibroblast cells (MRC-5; IC50 = 24 μM), the model for healthy cells.

Anticancer Activity and DNA Binding of a Bifunctional Ru(II) Arene Aqua-Complex with the 2,4-diamino-6-(2-pyridyl)-1,3,5-triazine ligand

BIVER, TARITA;
2013

Abstract

The synthesis and full characterization of the new aqua-complex [(η6-p-cymene)Ru(OH2)(κ2-N,N-2-pydaT)](BF4)2, [2](BF4)2, and the nucleobase derivative [(η6-p-cymene)Ru(9-MeG)(κ2-N,N-2-pydaT)](BF4)2, [4](PF6)2, where 2-pydaT = 2,4-diamino-6-(2-pyridyl)-1,3,5-triazine and 9-MeG = 9-methylguanine, are reported here. The crystal structures of both [4](PF6)2 and the chloro complex [(η6-p-cymene)RuCl(κ2-N,N-2-pydaT)](PF6), [1](PF6), have been elucidated by X-ray diffraction. The former provided relevant information regarding the interaction of the metallic fragment [(η6-p-cymene)Ru(κ2-N,N-2-pydaT)]2+ and a simple model of DNA. NMR and kinetic absorbance studies have proven that the aqua-complex [2](BF4)2 binds to the N7 site of guanine in nucleobases, nucleotides, or DNA. A stable bifunctional interaction (covalent and partially intercalated) between the [(η6-p-cymene)Ru(κ2-N,N-2-pydaT)]2+ fragment and CT-DNA has been corroborated by kinetic, circular dichroism, viscometry, and thermal denaturation experiments. The reaction mechanism entails the very fast formation of the Ru–O-(PO3) linkage prior to the fast intercalation of the 2-pydaT fragment. Then, a Ru–N7-(G) covalent bond is formed at the expense of the Ru–O-(PO3) bond, yielding a bifunctional complex. The dissociation rate of the intercalated fragment is slow, and this confers additional interest to [2](BF4)2 in view of the likely correlation between slow dissociation and biological activity, on the assumption that DNA is the only biotarget. Furthermore, [2](BF4)2 displays notable pH-dependent cytotoxic activity in human ovarian carcinoma cells (A2780, IC50 = 11.0 μM at pH = 7.4; IC50 = 6.58 μM at pH = 6.5). What is more, complex [2](BF4)2 is not cross-resistant with cisplatin, exhibiting a resistance factor, RF(A2780cis), of 0.28, and it shows moderate selectivity toward the cancer cell lines, in particular, A2780cis (IC50 = 3.0 5 ± 0.08 μM), relative to human lung fibroblast cells (MRC-5; IC50 = 24 μM), the model for healthy cells.
N., Busto; J., Valladolid; M., Martínez Alonso; H., Lozano; F., Jalón; B., Manzano; A., Rodríguez; M., Carrión; Biver, Tarita; J. L., Leal; G., Espino; B., Garcia
File in questo prodotto:
File Dimensione Formato  
43-RuAcquoBurgos InorgChem 2013.pdf

solo utenti autorizzati

Tipologia: Versione finale editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 2.1 MB
Formato Adobe PDF
2.1 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11568/237863
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 63
  • ???jsp.display-item.citation.isi??? 62
social impact